Saturday 17 October 2026
Export AMIX’s income statement to Excel — free account
Autonomix Medical, Inc.
AMIX Healthcare Medical Devices
In the quarter to June 2026, EPS grew 77.7% and free cash flow fell 36.1%, each against the same quarter a year earlier.
2.85
0.08
−2.73%
Follow AMIX
Target Price Range
Analyst price targets
Free accountTen years at a glance
| Group | Line | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Trend | 2027e | 2028e | 2029e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price, $ | |||||||||||||||
| Price, $ | Low | — | — | — | — | — | — | — | 60.48 | 9.89 | 2.44 |
Analyst estimates 2027–2029 Powerpack |
|||
| High | — | — | — | — | — | — | — | 3,192.00 | 78.96 | 24.68 | |||||
| People | |||||||||||||||
| People | Employees | — | — | — | — | — | — | — | 8 | 11 | 8 | ||||
| Revenue/emp, $m | — | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 | |||||
| Income, $m | |||||||||||||||
| Income, $m | Revenue | — | — | — | — | — | — | — | — | — | — | ||||
| Gross margin, % | — | — | — | — | — | — | — | — | — | — | |||||
| EBT | — | — | — | — | — | (1) | (3) | (15) | (11) | (17) | |||||
| EBT margin, % | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Net income | — | — | — | — | — | (1) | (10) | (15) | (11) | (17) | |||||
| Depreciation | — | — | — | — | — | 0 | 0 | 0 | 0 | 0 | |||||
| Per share, $ | |||||||||||||||
| Per share, $ | Revenue | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Earnings | — | — | — | — | — | — | (69.54) | (311.40) | (135.71) | (48.74) | |||||
| Cash flow | — | — | — | — | — | 0.00 | (0.23) | (134.30) | (98.19) | (35.76) | |||||
| Capex | — | — | — | — | — | 0.00 | 0.00 | (0.38) | (0.17) | (0.03) | |||||
| Free cash flow | — | — | — | — | — | 0.00 | (0.23) | (134.69) | (98.36) | (35.78) | |||||
| Book value | — | — | — | — | — | 0.00 | (0.29) | 154.10 | 96.30 | 17.16 | |||||
| Shares, m | — | — | — | — | — | — | 19 | 0 | 0 | 0 | |||||
| Valuation, × | |||||||||||||||
| Valuation, × | P/E | — | — | — | — | — | — | — | — | — | — | ||||
| P/S | — | — | — | — | — | — | — | — | — | — | |||||
| P/B | — | — | — | — | — | — | — | — | — | — | |||||
| EV/Sales | — | — | — | — | — | — | — | — | — | — | |||||
| EV/FCF | — | — | — | — | — | — | — | — | — | — | |||||
| Cash, $m | |||||||||||||||
| Cash, $m | Operating cash flow | — | — | — | — | — | (1) | (4) | (7) | (8) | (12) | ||||
| Capex | — | — | — | — | — | 0 | 0 | 0 | 0 | 0 | |||||
| Free cash flow | — | — | — | — | — | (1) | (4) | (7) | (8) | (12) | |||||
| Balance, $m | |||||||||||||||
| Balance, $m | Working capital | — | — | — | — | — | — | 1 | 9 | 8 | 6 | ||||
| Total debt | — | — | — | — | — | — | 1 | 1 | — | — | |||||
| Net debt | — | — | — | — | — | — | 0 | (8) | (9) | (7) | |||||
| Shareholders’ equity | — | — | — | — | — | — | (6) | 8 | 8 | 6 | |||||
| Returns, % | |||||||||||||||
| Returns, % | ROA | — | — | — | — | — | 0.00 | (232.83) | (275.07) | (118.77) | (192.06) | ||||
| ROIC | — | — | — | — | — | 0.00 | 0.00 | (34,176.14) | 0.00 | 0.00 | |||||
| ROE | — | — | — | — | — | 0.00 | 125.75 | (1,517.56) | (145.10) | (238.89) | |||||
Negative figures in brackets.
Charts ten years each
Autonomix Medical, Inc. vs peers in Medical Devices (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| WOK WORK Medical Technology Group LTD | $6.0M | — | — | — | — | −948.94% (below 0%: shrinking) | — | — | Compare |
| AMIX Autonomix Medical, Inc. | $5.7M | — (loss-making) | — | — | n/m | −36.10% (below 0%: shrinking) | — | 0.00% | |
| NVNO enVVeno Medical Corporation | $5.5M | — (loss-making) | — (loss-making) | +0.32% (above 0%: growing) | n/m | +4.60% (above 0%: growing) | 0.00% | 0.00% | Compare |
| CODX Co-Diagnostics, Inc. | $5.3M | — (loss-making) | — (loss-making) | +1.96% (above 0%: growing) | n/m | +17.47% (above 0%: growing) | 72.73% | (3,733.17%) | Compare |
| TBIO Telesis Bio Inc. | $5.3M | — (loss-making) | — (loss-making) | −61.79% (below 0%: shrinking) | n/m | −17.96% (below 0%: shrinking) | 64.43% | (349.74%) | Compare |
| VNRX VolitionRX Limited | $5.3M | — (loss-making) | — (loss-making) | −1.97% (below 0%: shrinking) | n/m | +18.58% (above 0%: growing) | 100.00% | (1,042.39%) | Compare |
| TRIB Trinity Biotech PLC | $5.1M | — (loss-making) | — (loss-making) | +43.28% (above 0%: growing) | n/m | +75.24% (above 0%: growing) | 35.43% | (24.53%) | Compare |
| VVOS Vivos Therapeutics, Inc. | $4.8M | — (loss-making) | — (loss-making) | +34.90% (above 0%: growing) | n/m | +16.44% (above 0%: growing) | 57.31% | (93.63%) | Compare |
| INBS Intelligent Bio Solutions Inc. | $4.8M | — (loss-making) | 5.4× | +51.10% (above 0%: growing) | n/m | −31.59% (below 0%: shrinking) | 43.23% | (360.19%) | Compare |
| Median of peers | $5.3M | — | — | +1.96% | — | +10.52% | 57.31% | (349.74%) |
Autonomix Medical, Inc. (AMIX) key facts
- Autonomix Medical, Inc. (AMIX) is a Medical Devices company in the Healthcare sector, listed on Nasdaq.
- As of October 16, 2026, AMIX traded at $2.85, a market capitalization of $5.7 million.
- Return on equity was −238.9% and debt-to-equity 0.00.